Two decades on the ground.
Five AI agents at the table.
Ahti Capital is a Hong Kong-based advisory bridging Nordic and European capital with Chinese and Asian buyers, sellers, and regulators. Founded by two partners with two decades of on-the-ground experience, and extended by a bench of purpose-built AI Agents that work every stage of the deal — from first search to post-merger integration.
Six disciplines. One cross-border deal team.
Every mandate draws on the same partnership and the same AI bench — there is no hand-off between origination and execution.
Investment Advisory
Capital allocation and entry-strategy guidance for Nordic and Asian investors approaching China- and Asia-originated opportunities.
M&A Advisory
Origination, negotiation, and execution of cross-border acquisitions and divestitures, buy-side and sell-side.
Corporate Finance
DCF modeling, capital structure, and credit negotiation grounded in institutional buy-side discipline, not banker shorthand.
Research
Proprietary valuation research, including doctoral-grade CLV/CAC modeling for Chinese platform and healthcare businesses.
Go-to-Market Services
Market-entry strategy and on-the-ground execution for companies entering China and the wider Asian market.
VC / PE Deal Support
Target sourcing, due diligence, and structuring support for venture and private equity sponsors active in the region.
We connect what others can't reach.
We work through and with extensive networks of investors, corporations, government institutions, and law firms — for origination, and for finding the buyer or seller who is actually willing to close.
Built over 20+ years
Based in Shanghai since 2003, bridging Nordic and European industrial capital with Chinese buyers, sellers, and regulators on the ground — backed by corporate finance grounding from KONE, Nokia, and Mannheimer Swartling.
Sell-side execution
A rare combination of institutional fund management experience (Legg Mason, LGPI, Aktia Asset Management) and hands-on deal execution (Fidens PE, Amphion Asia, Mannheimer Swartling) — valuations built the way investment committees actually scrutinize them, not the way bankers pitch them.
Not just one sector
Closed transactions spanning pharmaceuticals, mining, telecom LBOs, retail/e-commerce, and nutraceuticals across China, Sweden, Norway, Finland, and Hong Kong — structuring deals where jurisdictions, currencies, and regulatory regimes don't line up neatly.
Via doctoral research
Doctoral research on CLV/CAC-driven valuation of Chinese healthcare platforms underpins a proprietary, data-driven approach to valuation and synergy modeling — extended with applied AI/ML methods, not generic multiples. Particular depth in China's online healthcare market.
Partners, personally, end-to-end
Term sheet drafting, due diligence, DCF modeling, credit agreement negotiation — the partners stay personally involved through execution rather than handing off after sourcing, with a Morningstar #1-ranked fund management track record as evidence of the underlying investment discipline.
Five AI Agents. One deal team, working around the clock.
Every engagement is supported by a bench of purpose-built AI Agents — built on Coze, Manus, and Claude — that work alongside the partners at each stage of the deal lifecycle, from first target search to post-merger restructuring.
Continuously scans Nordic and Asian markets to identify and qualify acquisition targets, buyers, and counterparties against each client's mandate.
Builds and stress-tests valuation models, extending the partnership's doctoral-grade CLV/CAC methodology with applied AI/ML techniques.
Maps operational, commercial, and financial synergies between counterparties to inform positioning before term sheets are drawn.
Drafts term sheets and structures transactions across jurisdictions, currencies, and regulatory regimes that rarely line up neatly.
Supports negotiation strategy at the table and post-close restructuring, keeping partners informed in real time through to completion.
We build bridges where others see barriers.
- Pharmaceuticals & Nutraceuticals
- Mining & Minerals
- Telecommunication
- Retail / E-Commerce
- Marine & Offshore
- Education / Universities
- Healthcare (AI)
- Construction (Machinery)
- Chemicals
- Energy
- China
- Hong Kong
- Singapore
- Sweden
- Finland
- Norway
- Denmark
Morningstar #1-ranked fund management track record
The partnership's institutional fund management career — spanning Legg Mason, LGPI, and Aktia Asset Management — included a Morningstar #1-ranked track record, the same investment discipline now applied to every valuation and synergy model on the AI bench.
Two partners. Two sides of the same bridge.
Dr. Jack Ilmonen
PartnerA management consultant in China and Asia for over 20 years, Jack has helped western investors and corporations grow their businesses across the region. Previously a fund manager and analyst at Legg Mason, Aktia Asset Management, and the LGPI Pension Fund (US$60 billion AUM).
In recognition of this work, Jack was awarded the Knight's Cross, 1st Class, by the President of Finland, Dr. Alexander Stubb, for supporting Finnish companies in China and Asia and for advancing economic opportunity and growth in Finland.
Holds a DBA from ISC Paris Business School, with doctoral research applying a novel CLV/CAC-driven valuation model to Chinese online healthcare platforms — the methodological foundation for Ahti's research practice. Founder of Amphion Asia Consulting. Based in Shanghai.
Mikko Harju
PartnerMikko is a respected transaction and business lawyer with over 30 years of experience in demanding contract and licensing matters, as well as diverse corporate transactions such as M&A deals and private equity and venture capital arrangements.
He has worked as an attorney at leading law firms and consulting companies in both Finland and the Asia-Pacific region, and as in-house corporate counsel at leading technology companies listed on the stock exchange.
Bring us your cross-border mandate.
Whether you are a Nordic investor evaluating an entry into China, or a Chinese business seeking a Nordic or European counterparty — the first conversation costs nothing but an email.
mikko.harju@ahticapital.com